國內(nèi)外干細胞研究進展 文獻綜述

摘要: 干細胞研究是近年來生物醫(yī)學(xué)領(lǐng)域的熱門方向之一， 干細胞產(chǎn)業(yè)具有巨大的社會效益和市場前景受到世界各國的高度重視。美國、 歐盟、 日本、 韓國和中國在干細胞領(lǐng)域投入重金支持基礎(chǔ)和臨床研究， 大力推動干細胞產(chǎn)業(yè)化發(fā)展。 通過對比分析國內(nèi)外干細胞研究和產(chǎn)業(yè)化發(fā)展現(xiàn)狀， 我們發(fā)現(xiàn)中國對干細胞治療存在巨大的潛在需求。 近年來在干細胞研究和產(chǎn)業(yè)化方面也取得了較大進展， 但是與發(fā)達國家相比仍存在較大差距。 為搶占未來干細胞研究和產(chǎn)業(yè)發(fā)展的制高點， 中國應(yīng)該不斷加強干細胞研究的原始創(chuàng)新能力建設(shè)， 創(chuàng)新發(fā)展模式， 積極推動風(fēng)險投資和金融資本進入干細胞產(chǎn)業(yè)，重視配套法律法規(guī)建設(shè)， 大力推進干細胞產(chǎn)業(yè)發(fā)展

關(guān)鍵詞: 干細胞; 生物醫(yī)學(xué)研究; 全能性

Abstract: Stem cell ressearch is one of the hot research fields in biomedicine nowadays. Many countries attach importance to the stem cell industry because of the great benefits and market potenial. USA, EU, Japan, Korea and China have increased the input of capital dramatically to promote the basic and clinical research of stem cell as well as stem cell industry. By comparing the great demand lof stem cell. In recent years, an obvious progress has been made in both stem cell research and industry, however, the gap between China and the developed countries still exists. To seize a commanding elevation of stem cell research and industry, China should increase the original innovation ability of stem cell research, innovate the developmental patten, encourage venture capital to engage in stem cell industry and consummate the Chinese laws and regulations related to stem cell.

Key words:  Stem cell;  Biomedicine research ;  Almighty